Welcome to CenterNet's CME testing site for Type 1 Diabetes.
This continuing educational activity consists of a 1 hour video with a CME post test and evaluation form.
This activity should take about 1.5 hours to complete. To qualify for credit and receive a Certificate of Completion, the participant should:
1. review the objectives
2. watch the video
3. complete the viewer evaluation, post test, and CME application which are all available online at this website.
If you achieve a score of 70% or more, you will be able to print your CME certificate from this online site.
If you don't manage to achieve a passing score, you are welcome to try again.
If you have any difficulty printing out your certificate, please email cme@centernet-tv.com with your problem.
CME credit is available until May 2004 for this program. No credit will be given after that date.
Good Luck!

Objectives for Diabetes Type 1
• Understand the current research in prevention of type1diabetes
• Understand newer approaches to type1diabetes management
• Review key current recommendations for care of patients with type1diabetes
• Review key findings from clinical trails on which these recommendations are based.
• Identify collaborations needed for successful management of type 1 diabetes
• Identify strategies to establish a collaborative approach to care with both health professionals an the person with type 1 diabetes

Faculty Disclosures

Name

Grantee/Research

Consultant Speakers Bureau

Director

Stockholder/Optionee
Judith Fradkin, MD none none none none
Martha M. Funnell, MS, RN, CDE none none none none
Jay S. Skyler, MD 20,24,25,26,27,28 1,2,3,4,5,6,7,8,9,10,
11,12,13,14,15,16,17,
18,19,20,21,22,23		 1,17,31,33 1,9,12,17,20,29,
30,31,32,33,34
1.   Amylin Pharmaceuticals
2.   Aventis
3.   Bayer
4.   Boston Medical Technologies
5.   Bristol Myers Squibb
6.   Clinical Products, Ltd.
7.   Diabetogen
8.   Eli Lilly & company
9.   GMP Companies, Inc.
10. Glaxo Smith Kline
11. Institute for Diabetes Discovery
12. IVAX Corp.
13. Lipha Pharmaceuticals
14. MediSense/Abbott
15. Merck
16. Merrill Lynch
17. MiniMed, Inc.
18. Novartis
 		 19. Novo-Nordisk
20. Pfizer, Inc.
21. Pharmacia
22. Takeda America
23. Therasense
24. National Institutes of Health
25. American Diabetes Association
26. Juvenile Diabetes Foundation International
27. Novo Nordisk
28. Vector Medical
29. Andrx Corp.
30. Diasa, Inc.
31. Healthbanc, Inc.
32. Homes Diagnostics, Inc.
33. Precision Medical Devices, Inc.
34. Scios, Inc.

Accreditation Information

The NIH/FAES is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians.

The NIH/FAES designates this educational activity for a maximum of 1.5 hours in category 1 credit for each program (total of 15 hours for entire series) towards the AMA Physician’s Recognition Award. Each physician should claim only those hours of credit actually spent in the educational activity.

This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the National Institutes of Health/Foundation for Advanced Education in the Sciences (NIH/FAES) and The Association of Academic Health Centers (AHC).  The views presented here are those of the Roundtable panel members and not necessarily those of CenterNet, the producer, the Association of Academic Health Centers, the National Institute of Diabetes, Digestive and Kidney Diseases of the National Institutes of Health, or any government agency. Neither the National Institute of Diabetes, Digestive and Kidney Diseases of the National Institutes of Health, nor any other government agency endorse any particular drug or product. Before using or prescribing any product discussed in the video, clinicians should consult the full prescribing information.

CME Viewer Evaluation Form
Please complete the Continuing Medical Education online questionnaire.  The evaluation form provides each viewer the opportunity to rate the extent to which the educational objectives were met, the quality of the instructional process, the perception of enhanced professional effectiveness, the perception of commercial bias and his/her views on future education needs. To indicate your answers use the rating scale shown below by entering the number that represents your answer into the box to the right of each question. To move to the next question use your tab button. When you have completed the evaluation, please click on the "Take test" button at the bottom of the page.

1= none or not at all 2= very little 3= average 4= considerably 5= completely

1. Please rate the degree to which this program's objectives were attained:
• Understand the current research in prevention of type 1 diabetes
• Understand newer approaches to type 1 diabetes management
• Review key current recommendations for care of patients with type 1 diabetes
• Review key findings from clinical trails on which these recommendations are based
• Identify collaborations needed for successful management of type 1 diabetes
• Identify strategies to establish a collaborative approach to care with both health professionals and the person with type 1 diabetes

2. The quality of the instructional process was an asset to the program.

3. To what extent did participating in this activity enhance your professional effectiveness?

4. Please rate the quality of the graphics.

5. The instructions provided for the post test were clear and easy to follow.

6.  To what extent did the video: 
• Modify your opinion in this field?
• Modify your practice in this field?
• Reinforce your opinions in this field?
• Prepare you for your practice in this field?       

7.  Please rate the level of commercial bias in this educational activity.  

8.  Other topics you would like to see on video:

9.  Comments/suggestions:

Now that you have completed the evaluation, click below to take the test.